Synergistic Effect of Persistent Chlamydia pneumoniae Infection, Autoimmunity, and Inflammation on Coronary Risk
- 27 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (20) , 2566-2570
- https://doi.org/10.1161/01.cir.0000068338.17948.22
Abstract
Background— Given the role of chronic infections, autoimmunity, and inflammation in atherosclerosis, we studied the joint effect of chronic Chlamydia pneumoniae infection, persistently elevated human heat-shock protein 60 (hHsp60) antibodies, and C-reactive protein (CRP) on coronary risk. Methods and Results— The participants for this prospective nested case-control study were obtained from the Helsinki Heart Study, during which 241 nonfatal myocardial infarctions or coronary deaths occurred among 4081 dyslipidemic middle-aged men. Serum samples taken at baseline and 3 to 6 months before the coronary events that occurred during the 8.5-year period were analyzed for antibodies to C pneumoniae and hHsp60 and the CRP concentration. Compared with persistently low levels, the risk of coronary events was 2-fold for persistently elevated immunocomplex (IC)-bound and/or serum IgA antibodies to C pneumoniae (OR, 1.96; 95% CI, 1.14 to 3.36) and also for serum IgA antibodies to hHsp60 (OR, 2.11; 95% CI, 1.08 to 4.13). The risks associated with elevated antibodies were much higher when CRP was also elevated. Compared with low or transiently elevated levels, the risk of coronary events, with adjustment for age and smoking, was 4.5-fold for persistently elevated CRP and C pneumoniae IC/IgA antibodies together (OR, 4.47; 95% CI, 1.84 to 10.83) and was similar for CRP and hHsp60 IgA antibodies together (OR, 4.36; 95% CI, 1.53 to 12.39). Conclusions— Persistently but not transiently elevated C pneumoniae IC/IgA and hHsp60 IgA antibodies, especially when present together with an elevated CRP level, predicted coronary events.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysisPublished by Oxford University Press (OUP) ,2002
- Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Commentary: Adjustment for potential confounders may have been taken too farBMJ, 2000
- Background and Current Knowledge ofChlamydia pneumoniaeand AtherosclerosisThe Journal of Infectious Diseases, 2000
- Cellular Oxidation of Low‐Density Lipoprotein byChlamydia pneumoniaeThe Journal of Infectious Diseases, 1999
- Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophagesJournal of Clinical Investigation, 1999
- Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action ofHelicobacter pyloriand other bacterial infections in increasing cardiovascular riskEuropean Heart Journal, 1998
- Repeated and persistent infection with Chlamydia and the development of chronic inflammation and diseaseTrends in Microbiology, 1994
- The Helsinki Heart Study: coronary heart disease incidence during an extended follow‐upJournal of Internal Medicine, 1994
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987